Home › Trial NCT01910025
PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy
- Trial IDNCT01910025
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorPolaris Group
- Enrollment18
- Start date2013-12-06
- ConditionsNon-Hodgkin's Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.